Silvia Veneroni

3.0k total citations
54 papers, 2.4k citations indexed

About

Silvia Veneroni is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Silvia Veneroni has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 24 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Silvia Veneroni's work include Breast Cancer Treatment Studies (12 papers), Cancer Genomics and Diagnostics (9 papers) and Cancer-related Molecular Pathways (7 papers). Silvia Veneroni is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Cancer Genomics and Diagnostics (9 papers) and Cancer-related Molecular Pathways (7 papers). Silvia Veneroni collaborates with scholars based in Italy, United Kingdom and China. Silvia Veneroni's co-authors include Maria Grazia Daidone, Elvira Benini, Rosella Silvestrini, Umberto Veronesi, Patrizia Boracchi, G. Di Fronzo, Danila Coradini, R Silvestrini, Vera Cappelletti and Franco Rilke and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Silvia Veneroni

53 papers receiving 2.3k citations

Peers

Silvia Veneroni

ONCOL

PFM

PRM

Valérie‐Jeanne Bardou France

Jens K. Habermann Germany

Rabiul Islam United States

Ellen C.M. Mommers Netherlands

E. Berns Netherlands

Sten Wingren Sweden

Debora Fumagalli Belgium

Bethan Powell United States

Oscar Krijgsman Netherlands

Matthias Christgen Germany

Valérie‐Jeanne Bardou France

Silvia Veneroni

895 ×0.7

ONCOL

611 ×0.5

698 ×0.7

228 ×0.7

PFM

249 ×0.9

PRM

Citations per year, relative to Silvia Veneroni Silvia Veneroni (= 1×) peers Valérie‐Jeanne Bardou

Countries citing papers authored by Silvia Veneroni

Since Specialization

Citations

This map shows the geographic impact of Silvia Veneroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Veneroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Veneroni more than expected).

Fields of papers citing papers by Silvia Veneroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Veneroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Veneroni. The network helps show where Silvia Veneroni may publish in the future.

Co-authorship network of co-authors of Silvia Veneroni

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Veneroni. A scholar is included among the top collaborators of Silvia Veneroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Veneroni. Silvia Veneroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ciniselli, Chiara Maura, Michelandrea De Cesare, Gennaro Colella, et al.. (2022). miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma. Cancer Gene Therapy. 29(10). 1394–1404. 7 indexed citations

Appierto, Valentina, Marco Silvestri, Rosalba Miceli, et al.. (2021). Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy. ESMO Open. 6(2). 100086–100086. 47 indexed citations

Gennaro, Massimiliano, Serena Di Cosimo, Ilaria Ardoino, et al.. (2018). Dynamics of the hazard for distant metastases after ipsilateral breast tumor recurrence according to estrogen receptor status: An analysis of 2851 patients. The Breast. 40. 131–135. 4 indexed citations

Veneroni, Silvia, Matteo Dugo, Maria Grazia Daidone, et al.. (2016). Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues. Biopreservation and Biobanking. 14(6). 480–490. 9 indexed citations

Ciniselli, Chiara Maura, Michele De Bortoli, Luca Varinelli, et al.. (2015). Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone. Expert Review of Proteomics. 12(6). 695–701. 21 indexed citations

Folini, Marco, Paolo Gandellini, Nicole Longoni, et al.. (2010). miR-21: an oncomir on strike in prostate cancer. Molecular Cancer. 9(1). 12–12. 198 indexed citations

Callari, Maurizio, Vera Cappelletti, Loris De Cecco, et al.. (2010). Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Research and Treatment. 127(3). 601–610. 71 indexed citations

Daidone, Maria Grazia, Danila Coradini, Gabriele Martelli, & Silvia Veneroni. (2003). Primary breast cancer in elderly women: biological profile and relation with clinical outcome. Critical Reviews in Oncology/Hematology. 45(3). 313–325. 100 indexed citations

Coradini, Danila, Elia Biganzoli, Cinzia Pellizzaro, et al.. (2003). Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. British Journal of Cancer. 89(2). 268–270. 15 indexed citations

10.

Laccabue, Diletta, Monica Tortoreto, Silvia Veneroni, et al.. (2001). A novel taxane active against an orthotopically growing human glioma xenograft. Cancer. 92(12). 3085–3092. 16 indexed citations

11.

Daidone, Maria Grazia, Silvia Veneroni, Elvira Benini, et al.. (1999). Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer. International Journal of Cancer. 84(6). 580–586. 46 indexed citations

12.

Daidone, Maria Grazia, A Luisi, Silvia Veneroni, Elvira Benini, & Rosella Silvestrini. (1999). Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.. Endocrine Related Cancer. 6(1). 61–68. 68 indexed citations

13.

Silvestrini, R, Aurora Costa, Cosimo Lequaglie, et al.. (1998). Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 432(5). 441–444. 24 indexed citations

14.

Licitra, Lisa, Silvia Veneroni, Maria Grazia Daidone, et al.. (1998). Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. International Journal of Cancer. 79(6). 619–623. 27 indexed citations

15.

Daidone, Maria Grazia, Rosella Silvestrini, A Luisi, et al.. (1995). Changes in biological markers after primary chemotherapy for breast cancers. International Journal of Cancer. 61(3). 301–305. 39 indexed citations

16.

Silvestrini, Rosella, Elvira Benini, Maria Grazia Daidone, et al.. (1993). p53 as an Independent Prognostic Marker in Lymph Node-Negative Breast Cancer Patients. JNCI Journal of the National Cancer Institute. 85(12). 965–970. 210 indexed citations

17.

Veneroni, Silvia, Maria Grazia Daidone, G. Di Fronzo, et al.. (1993). Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables. Breast Cancer Research and Treatment. 26(1). 7–13. 11 indexed citations

18.

Costa, A., et al.. (1992). Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma. British Journal of Cancer. 66(4). 680–684. 15 indexed citations

19.

Silvestrini, Rosella, et al.. (1988). Comparative Analysis of Different Approaches to Investigate Cell Kinetics. Cell Proliferation. 21(2). 123–131. 69 indexed citations

20.

Veneroni, Silvia, et al.. (1988). Comparative analysis of [³H]‐thymidine labelling index and monoclonal antibody Ki‐67 in non‐Hodgkin's lymphomas. Hematological Oncology. 6(1). 21–28. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact